Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer
Highlights Reduced aPKC drives HA deposition, the mCRC phenotype, and predicts poor survival• HA enhances malignancy and promotes CAF and epithelial heterogeneity in mCRC• Immunosuppression